Tuesday Seminar Series

TUESDAY SEMINAR SERIES

The 2017 Tuesday Seminars will be held on the first Tuesday of each month from Tuesday 7 March through to December. The objectives of this seminar series are to build further knowledge in innovative medical research, development and translation; and to attract renown speakers on topics that will be relevant to a broad audience.

The Tuesday Seminars are free to attend, simply come along to the Autidorium at the TRI building, no RSVP is required. 

Featured Seminar 

Our next Tuesday Seminar Series features Australian of the Year Alan Mackay-Sim, presenting "Hereditary Spastic Paraplegia: from stem cells to drug discovery" on 30 May. 

Alan Mackay-Sim is a neuroscientist and stem cell scientist.

He graduated with a PhD from Macquarie University in 1980 and worked at the University of Sydney, the University of Pennsylvania, the University of Wyoming and the University of Adelaide before taking up a position at Griffith University in 1987. In 2015 he retired and was appointed Emeritus Professor.

His research has encompassed the human sense of smell and how the olfactory sensory neurons in the nose get regenerated throughout life. He identified the olfactory stem cell in the nose that is responsible for the regeneration of the sense of smell and uses these “adult” stem cells and other olfactory cells from the nose for therapeutic purposes.

Alan is a world leader in spinal cord injury research using nasal olfactory cells. He led a team from Brisbane in a world-first clinical trial in which the patient’s own olfactory cells were transplanted into their injured spinal cord in the first stages of a therapy to treat human paraplegia.

Alan established the National Centre for Adult Stem Cell Research in 2006 and built an adult stem cell bank with cells from more than 300 people with different neurological conditions including schizophrenia, Parkinson’s disease, mitochondrial mutation disorders, Hereditary Spastic Paraplegia, ataxia telangiectasia and motor neuron disease.

These stem cells are used to identify the biological bases of neurological diseases using genomics, proteomics and cell function assays and this work is leading to new drug therapies. Alan is 2017 Australian of the Year.

2017 Schedule

Date & Time

Time Featured Speaker TRI Host Title & Abstract

30 May 2017 *Please note date change

12.00 - 1.00pm 

Prof Alan Mackay-Sim, 2017 Australian of the Year

Dr Alexandre Cristino

Hereditary Spastic Paraplegia: from stem cells to drug discovery

6 June 2017

12.00 - 1.00pm 

A/Prof Michael Samuel, Head Tumour Microenvironment Lab, Centre for Cancer Biology,

SA Pathology & the University of South Australia

Prof Rik Thompson

Biochemical and biomechanical inter-relationships in cancer and wound healing

20 June 2017

12.00 - 1.00pm 

Prof Cornellia Weyand, Medicine - Immunology and Rheumatology, Stanford

Prof Ranjeny Thomas

Immune ageing and genomic stress in the pathogenesis of humane autoimmune diseases

25 July 2017

12.00 - 1.00pm

Dr Jonathan Sherlock, Kennedy Institute of Rhuematology, University of Oxford

Prof Ranjeny Thomas

Immunological pathways implicated in autoimmune diseases

4 July 2017

12.00 - 1.00pm 

Professor Nick Graves, Health Economist, QUT

Professor Gerald Holtmann

Calculating the financial benefits of your project

5 September 2017

TBC

Program in development

Louise Morland

Imagine 2017

3 October 2017

12.00 - 1.00pm 

Prof Roger Daly, Molecular Biology, Monash University

Prof Brian Gabrielle

TBC

18-21 October 2017

TBC

TBC

Prof Peter Soyer

Special Seminar - 9th World Congress - Melanoma

7 November 2017

TBC

TBC

TBC

TBC

5 December 2017

12.00 - 1.00pm

Dr Giulia Rancati, IMB, A*STAR, Singapore

A/Prof Helmut Schaider

Mechanisms of eukaryotic evolution: from yeasts to cancer cells

TRI based researchers, if you'd like to nominate a speaker, please contact them to ascertain their availability. If the speaker would like to present at TRI, please complete the online form and submit to the Personal Development and Talent Management Committee who will evaluate each submission. If you have any questions, please email: [email protected]

Auditorium
Seminar